BNET Plunges into Red with $11.7M Loss, Faces Liquidity Crisis

TL;DR

**BNET is a speculative bet on unproven tech with a collapsing balance sheet; avoid until significant funding and commercial traction materialize.**

AI Summary

Bion Environmental Technologies Inc. (BNET) reported substantial financial and management stress for the fiscal year ended June 30, 2025. The company is not generating significant revenues, with current liabilities increasing by approximately $1.4 million to $7.1 million at June 30, 2025, largely due to new debt and increased deferred compensation. Cash on hand plummeted from approximately $52,000 to $4,400 over the same period. A significant non-cash charge of $9,460,425 was taken due to writing down the Initial Project (Ammonia Recovery System at Fair Oaks) to $0, resulting in a net loss of $11,691,115 for the 2024 fiscal year and reducing shareholders' equity to negative $5,808,501. The company defaulted on a $1.5 million bridge loan from SEB LLC after only receiving the initial $250,000 tranche, leading to lawsuits from two largest creditors totaling $1,494,512.72. Despite these challenges, Bion achieved key objectives in optimizing its Ammonia Recovery System at Fair Oaks and secured a new patent broadening its ARS claims to include industrial and municipal wastewater. A new leadership team, including interim CEO Craig Scott and COO Greg Schoener, was installed in May/June 2024, and efforts are underway to pursue longer-term capital solutions and strategic partnerships, including a potential 16,000-head sustainable beef project with Turk Stovall.

Why It Matters

BNET's precarious financial state, marked by a negative $5.8 million shareholder equity and a mere $4,400 in cash, signals extreme risk for investors. The write-down of its flagship Ammonia Recovery System to zero and ongoing litigation from creditors highlight severe operational and financial mismanagement, eroding investor confidence. For employees, the instability raises concerns about job security and the company's long-term viability. In the broader market, Bion's struggles underscore the challenges faced by early-stage environmental technology companies in securing consistent funding and scaling operations, especially when competing with established players or facing economic headwinds.

Risk Assessment

Risk Level: high — The company's risk level is high due to its current liabilities of approximately $7.1 million far exceeding its cash on hand of $4,400 as of June 30, 2025. A $9,460,425 non-cash charge for writing down the Initial Project to $0 resulted in a $11,691,115 loss for fiscal year 2024 and negative shareholders' equity of ($5,808,501). Furthermore, Bion defaulted on a $1.5 million bridge loan and faces lawsuits totaling $1,494,512.72 from its two largest creditors.

Analyst Insight

Investors should exercise extreme caution and consider divesting BNET shares given the severe liquidity crisis, negative equity, and ongoing litigation. New investors should avoid BNET until the company demonstrates a clear path to sustainable revenue generation, secures substantial long-term financing, and resolves its significant debt and legal challenges.

Financial Highlights

debt To Equity

N/A

revenue

$0

operating Margin

N/A

total Assets

N/A

total Debt

N/A

net Income

-$11,691,115

eps

N/A

gross Margin

N/A

cash Position

$4,400

revenue Growth

N/A

Revenue Breakdown

Key Numbers

• $7.1 million — Current Liabilities (increased by $1.4 million from June 30, 2024)
• $4,400 — Cash on Hand (decreased from $52,000 over the same period)
• $9,460,425 — Non-cash charge (due to write-down of Initial Project to $0)
• $11,691,115 — Net Loss (for the 2024 fiscal year)
• ($5,808,501) — Shareholders' Equity (negative after the write-down)
• $1,500,000 — Bridge Loan (from SEB LLC, defaulted after initial $250,000 tranche)
• $1,494,512.72 — Lawsuits from creditors (total amount sought by two largest creditors)
• 14,369,659 — Net reduction in fully diluted shares (due to settlement agreements with Holders)
• 8,101,746 — Increase in outstanding shares (due to settlement agreements with Holders)
• 16,000 — Head of cattle (planned for sustainable beef project at Yellowstone Cattle Feeders)

Key Players & Entities

• BION ENVIRONMENTAL TECHNOLOGIES INC (company) — Registrant
• Dominic Bassani (person) — deceased former CEO and COO
• Bill O'Neill (person) — resigned CEO and Director
• Mark A. Smith (person) — retired President, General Counsel, and CFO
• SEB LLC (company) — bridge loan lender in default
• Titan Partners (company) — NY investment banking firm
• Craig Scott (person) — interim Chief Executive Officer and Director
• Greg Schoener (person) — interim Chief Operating Officer and Director
• Turk Stovall (person) — strategic partner for Yellowstone Cattle Feeders project
• Yellowstone Cattle Feeders (company) — location for 16,000-head sustainable beef project

FAQ

Risk Factors

• Severe Liquidity Constraints [high — financial]: The company has experienced extreme difficulties in raising needed funds, with cash on hand plummeting from $52,000 to $4,400 between June 30, 2024, and June 30, 2025. Current liabilities increased by $1.4 million to $7.1 million, driven by new debt and deferred compensation, indicating significant financial stress.
• Default on Loan and Creditor Lawsuits [high — legal]: Bion defaulted on a $1.5 million bridge loan from SEB LLC after receiving only $250,000, leading to lawsuits from two largest creditors totaling $1,494,512.72. This highlights significant legal and financial repercussions from funding shortfalls.
• Project Delays and Write-downs [high — operational]: Covid-related delays and supply chain disruptions impacted project development, leading to a substantial non-cash charge of $9,460,425 due to writing down the Initial Project (Ammonia Recovery System at Fair Oaks) to $0. This resulted in a net loss of $11,691,115 for fiscal year 2024.
• Negative Shareholders' Equity [high — financial]: The significant write-down of the Initial Project resulted in shareholders' equity becoming negative $5,808,501 as of June 30, 2024. This indicates the company's liabilities exceed its assets, a critical indicator of financial distress.
• Leadership Transition and Uncertainty [medium — management]: The company has experienced significant management turnover, including the death of the COO, resignation of the CEO, and retirement of the President, General Counsel, and CFO. While a new team was installed in May/June 2024, the recent history of leadership instability poses an operational risk.
• Dependence on Future Funding and Partnerships [high — market]: The company's ability to execute its business plan is heavily reliant on securing longer-term capital solutions and strategic partnerships. Without sufficient financing and alignment with partners, the company's anticipated revenues will not meet operational and capital needs.

Industry Context

Bion operates at the intersection of sustainable agriculture, renewable energy, and environmental technology. Key trends favor its ammonia control and recovery solutions, including growing demand for sustainable farming practices and clean fuels. The biogas sector, a potential feedstock source, is also expanding, driven by renewable energy policy. However, the industry faces challenges related to capital intensity and the need for proven, scalable technologies.

Regulatory Implications

The company's technology addresses environmental concerns related to ammonia emissions, which are subject to increasing regulatory scrutiny in agriculture and industrial wastewater. Securing patents for its ARS technology, including for industrial and municipal wastewater, positions Bion to benefit from stricter environmental regulations and incentives for clean technologies.

What Investors Should Do

1. Monitor cash burn and liquidity closely.
2. Evaluate the viability of new leadership and strategic partnerships.
3. Assess the legal and financial implications of creditor lawsuits.
4. Analyze the potential market adoption of the ARS technology.

Key Dates

• 2024-05-31: CEO Bill O'Neill resigned — Marked a significant leadership change following the death of the previous COO/CEO, leading to the installation of a new core leadership team shortly after.
• 2024-06-30: Fiscal Year End — Reported substantial net loss of $11,691,115, negative shareholders' equity of ($5,808,501), and a sharp decline in cash to $4,400.
• 2024-07-31: President, General Counsel, and CFO Mark A. Smith retired — Continued management transition, highlighting a period of significant leadership changes.
• 2025-06-30: Fiscal Year End — Current liabilities increased to $7.1 million, and cash on hand further decreased to $4,400, underscoring ongoing financial distress.

Glossary

Ammonia Recovery System (ARS)

A technology designed to capture and recover ammonia, often from waste streams, for reuse, such as in fertilizer production. (This is Bion's core technology, with a demonstration facility at Fair Oaks. The company secured a new patent broadening its ARS claims.)

Deferred Compensation

Compensation earned by an employee in one period but paid in a future period. It represents a liability for the company. (An increase in deferred compensation contributed to the rise in current liabilities, indicating potential future cash outflows.)

Shareholders' Equity

The residual interest in the assets of an entity after deducting all its liabilities. It represents the net worth of the company. (Bion's shareholders' equity is negative ($5,808,501), indicating insolvency and a significant risk to investors.)

Non-cash Charge

An expense recorded on the income statement that does not involve an outflow of cash during the period. Examples include depreciation or asset write-downs. (A $9,460,425 non-cash charge from an asset write-down significantly impacted the company's net loss for the fiscal year.)

Bridge Loan

A short-term loan used to cover a gap in financing until a company can secure more permanent funding. (The company defaulted on a $1.5 million bridge loan, leading to legal action and highlighting severe funding challenges.)

Year-Over-Year Comparison

The fiscal year ended June 30, 2025, shows a significant deterioration in Bion's financial health compared to the prior year. Revenue remains negligible, but current liabilities have increased by approximately $1.4 million to $7.1 million, largely due to new debt and deferred compensation. Cash on hand has plummeted from $52,000 to $4,400, indicating a severe liquidity crisis. The company also incurred a substantial non-cash charge of $9,460,425, leading to a net loss of $11,691,115 and negative shareholders' equity of ($5,808,501), a stark contrast to potentially less severe financial metrics in the previous period.

Key Financial Figures

• $7.1 million — Current liabilities were approximately $7.1 million at June 30, 2025 which represents an in
• $1,400,000 — represents an increase of approximately $1,400,000 from June 30, 2024 (largely due to new
• $52,000 — sh on hand decreased from approximately $52,000 to approximately $4,400 over the same p
• $4,400 — approximately $52,000 to approximately $4,400 over the same period. The Company has f
• $0 — Project, as of that date, be reduced to $0 on the Company balance sheet, in order
• $9,460,425 — time/non-recurring' non-cash' charge of $9,460,425 was taken by the Company, at that date,
• $5,808,501 — ed the Company shareholders' equity to ($5,808,501) and resulted in a loss of $11,691,115
• $11,691,115 — ($5,808,501) and resulted in a loss of $11,691,115 for the 2024 fiscal year. 1 C: On Se
• $1,500,000 b — Company entered into an agreement for a $1,500,000 bridge loan and executed documents includ
• $1,500,000 — required the Lender to loan the Company $1,500,000 in six monthly tranches of $250,000 com
• $250,000 — y $1,500,000 in six monthly tranches of $250,000 commencing October 2023. All sums advan
• $1.00 — the Company. The Note is convertible at $1.00 per unit, at the sole election of the L
• $1,494,512.72 — ts (see O, below) to recover a total of $1,494,512.72 in unpaid invoices related to the const
• $150,000 — . On May 10, 2024 the Company received $150,000 from affiliates of the Bridge Loan Lend
• $56,250 — im (2,425,000, in aggregate) and waived $56,250 of accrued deferred compensation (conve

Filing Documents

• bion_10k-063025.htm (10-K) — 1394KB
• ex19x1.htm (EX-19.1) — 48KB
• ex31x1.htm (EX-31.1) — 9KB
• ex31x2.htm (EX-31.2) — 7KB
• ex32x1.htm (EX-32.1) — 5KB
• ex32x2.htm (EX-32.2) — 4KB
• image_002.jpg (GRAPHIC) — 56KB
• 0001079973-25-001516.txt ( ) — 6024KB
• bnet-20250630.xsd (EX-101.SCH) — 50KB
• bnet-20250630_cal.xml (EX-101.CAL) — 48KB
• bnet-20250630_def.xml (EX-101.DEF) — 189KB
• bnet-20250630_lab.xml (EX-101.LAB) — 325KB
• bnet-20250630_pre.xml (EX-101.PRE) — 279KB
• bion_10k-063025_htm.xml (XML) — 756KB

FORWARD-LOOKING STATEMENTS

FORWARD-LOOKING STATEMENTS This Annual Report on Form 10-K (and the documents incorporated herein by reference) contain forward-looking statements, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), that involve substantial risks and uncertainties.

Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will,"

Forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "will," "expect," "intend," "estimate," "anticipate," "project," "predict," "plan," "believe," or "continue," or the negative thereof or variations thereon and/or references to goals, targets, projections or similar terminology. The expectations reflected in forward-looking statements may prove to be incorrect. These forward-looking statements include, but are not limited to, predictions regarding: our business plan; the commercial viability of our technology and products produced by our technology; the effects of competitive factors on our technology and products produced by our technology; expenses we will incur in operating our business; our liquidity and sufficiency of existing cash; the success of our financing plans; and the outcome of pending or threatened litigation. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that the expectations underlying our forward-looking Therefore, you should not place undue reliance on our forward-looking statements. We have included important risks and uncertainties in the cautionary statements included in this Annual Report; particularly, the section titled "Risk Factors" incorporated in Item 1.A of this report. These risks and uncertainties could cause actual results or events to differ materially from the forward-looking or expectations prove incorrect, actual results, performance or financial condition may vary materially and adversely from those anticipated, estimated or expected. Our forward-looking statements do not reflect the potential imp

BUSINESS

ITEM 1. BUSINESS. GENERAL The Company has been under substantial financial and management stress over the past eighteen (18) months. Covid-related delays during technology pilot development at Buflovak in New York, followed by post-Covid supply chain disruptions during construction of our demonstration facility at Fair Oaks, have led to extreme difficulties in raising needed funds. These delays prevented us from meeting our project development and related capital timelines, and were further compounded by the death (following extended illness) of Dominic Bassani, who most recently served as our COO from May 2022 after serving as our CEO for the prior decade, the subsequent resignation of Bill O'Neill, Dominic's replacement at the CEO position, effective May 31, 2024, followed by the retirement of Mark A. Smith, the Company's President, General Counsel and Chief Financial Officer, effective July 31, 2024. At the end of May 2024, a new core leadership team was installed (see H and I, below) and a short-term funding strategy was implemented (see K, below) while longer term capital solutions were pursued. These efforts are ongoing. Our new leadership team believes the difficulties Bion has faced are outweighed by our recent successes that include the technology demonstration and optimization at our Fair Oaks facility and the initial responses from our fertilizer outreach. This is coupled with strong recent interest in our ammonia control solution from the biogas operators and developers that will be needed to ensure a supply of feedstock for our fertilizer products. These successes coincide with growing trends in sustainable agriculture and clean fuels technology and policy that favor Bion's business opportunities. Bion leadership believes this confluence of events positions the Company, assuming it aligns with appropriate strategic partners and obtains sufficient financing, to exploit a unique opportunity at the intersection of agriculture, renewable energy, the en

View Full Filing

View this 10-K filing on SEC EDGAR